Advancing Biopharmaceuticals
and Medical Technologies
in Cardiovascular Medicine

COVID-19 Keeping up trial safety and progress


Accelerate Your Research in Cardiovascular Trials

is a full-service contract research organization (CRO) specialized in cardiovascular research. Our services cover the whole spectrum of development.


We Share Your Enthusiasm for Finding Effective Therapies

works with biopharmaceutical and medical technology companies across all phases of development. Our deep expertise in cardiovascular medicine makes us a strong partner for your cardiovascular trials.


Together We Find the Right Solution

Accessible and responsive leadership, dedicated staff, and a specialized site network – this is how we help study sponsors develop innovative therapies.


Clients & Partners


Discover the latest updates on cardiovascular research

Comprehensive Approach to Phase 1 Cardiovascular Studies

Integrating Phase 1 Studies in Healthy Volunteers and Patients with Cardiovascular Disease – A Comprehensive Approach  

Phase 1 clinical studies are the initial step in drug development, designed to assess the safety and tolerability of a new molecule in humans. Traditionally investigational medicinal products (IMP) were tested in multiple Phase 1 clinical trials that enrolled large...
Single researcher analyzing cardiovascular research data on a large monitor in a professional office setting, showing deep concentration and note-taking.

Site Management and Study Start-Up Enhancement: A Strategic Focus in Cardiovascular Research

Insights into best practices and efficiency improvement in clinical trials highlight the importance of thorough site identification and selection in the field of cardiovascular research. Managing the complex regulatory environment requires well-thought-out document management and early engagement with regulatory authorities....
A detailed overview of cardiovascular clinical trials showcasing the strategic importance of partnering with specialist CROs for enhanced trial efficiency and success.

Maximizing Success in Cardiovascular Trials: The Advantage of Partnering with a Specialist CRO

The industry spent over $200 billion globally in 2021 on developing new therapies for treating cardiovascular diseases. However, it’s estimated that more than half of the investment in clinical development is wasted. Various factors contribute to this, including a lack...

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Thank you for your application.

We will get in touch shortly.